advisorsecurities master

PRPOPrecipio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
20366
Ticker
PRPO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2000-07-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
PRPO

Detail

Enriched 2026-08-14 20:47

Market cap
$40,287,364.88
Shares outstanding (class)
1,787,372
Shares outstanding (weighted)
1,787,372
SIC
3826 LABORATORY ANALYTICAL INSTRUMENTS
Employees
71
Location
NEW HAVEN, CT
Description

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data